The transcription factor Early Growth Response 3 (Egr3) has been shown to play an important role in negatively regulating T cell activation and promoting T cell anergy in Th1 cells. However, its role in regulating other T helper subsets has yet to be described. We sought to determine the role of Egr3 in a Th17 response using transgenic mice that overexpress Egr3 in T cells (Egr3 TG). Splenocytes from Egr3 TG mice demonstrated more robust generation of Th17 cells even under non-Th17 skewing conditions. We found that while Egr3 TG T cells were not intrinsically more likely to become Th17 cells, the environment encountered by these cells was more conducive to Th17 development. Further analysis revealed a considerable increase in the number of cd T cells in both the peripheral lymphoid organs and mucosal tissues of Egr3 TG mice, a cell type which normally accounts for only a small fraction of peripheral lymphocytes. Consistent with this marked increase in peripheral cd T cells, thymocytes from Egr3 TG mice also appear biased toward cd T cell development. Coculture of these Egr3-induced cd T cells with wildtype CD4+ T cells increases Th17 differentiation, and Egr3 TG mice are more susceptible to bleomycin-induced lung inflammation. Overall our findings strengthen the role for Egr3 in promoting cd T cell development and show that Egr3-induced cd T cells are both functional and capable of altering the adaptive immune response in a Th17-biased manner. Our data also demonstrates that the role played by Egr3 in T cell activation and differentiation is more complex than previously thought.
Introduction
Early growth response 3 (Egr3) is an immediate early zinc finger transcription factor activated in response to a variety of mitogenic signals [1] . Within the lymphocyte compartment, both mature and developing T cells highly express Egr3 shortly after TCR or pre-TCR engagement in a Ca 2+ and NFAT-dependent manner [2, 3] . Our group has previously demonstrated a role for Egr3 in negative regulation of mature CD4 T cell function. In vitro anergized and self-antigen tolerized CD4+ T cells express significantly higher levels of Egr3 than cells fully activated in the presence of costimulation [4, 5] . Additionally, the overexpression of Egr3 in T cells promotes an anergic phenotype, inhibiting both proliferation and IL-2 production, while T cells lacking Egr3 are hyperresponsive to activation and fail to become tolerized in in vivo models of anergy [4, 5] . Egr3 negatively regulates T cell activation by inhibiting genes that induce IL-2 transcription [6] and by promoting transcription of FasL [7] and E3 ubiquitin ligases, which target proteins involved in TCR signaling for degradation [4, 8, 9] . Although its importance in T cell anergy has been established, these experiments were focused on Th1 effector cells. The influence of Egr3 on the development of other T helper subsets has not been previously investigated.
Th17 cells are critical in the defense against certain bacterial and fungal infections but also contribute to the pathogenesis of a number of autoimmune diseases. These cells produce the proinflammatory cytokines IL-17, IL-21, and IL-22 and their differentiation relies on the activation and expression of the transcription factors STAT3 and RORct [10] [11] [12] . The precise mechanism by which Th17 T cells are produced in vivo remains controversial, but can involve IL-6 and TGFb, IL-23 and IL-1, or some combination of these cytokines, with IL-23 believed to help maintain the Th17 phenotype or perhaps promote Th17 pathogenicity [13] [14] [15] [16] . Many cell types can contribute to the Th17-biasing cytokine milieu, including nonlymphoid epithelial cells, innate immune cells like macrophages, DCs, and neutrophils, or even other activated T cells [17] [18] [19] . In addition to the downregulation of T cell activation machinery, Egr3 is thought to function in T cell development in part by inhibiting the function of RORct in thymocytes [20] , suggesting Egr3 might inhibit both Th1 and Th17 differentiation.
We sought to determine the role of Egr3 in the Th17 response using mice that transgenically overexpress Egr3 in T cells (Egr3  TG) . Surprisingly, we found an increased proportion of CD4+ T cells from these mice produced IL-17 when stimulated under nonskewing conditions. This increase in Th17 cells does not appear to be a direct result of Egr3 overexpression, but instead correlates with an increase cd T cell production in Egr3 TG mice. Our data highlight the ability of peripheral cd T cells to markedly influence the adaptive helper T cell response. We show here that these Egr3-induced cdT cells function similarly to wildtype cdT cells, in that they produce Th17-polarizing cytokines, are capable of skewing CD4+ T cells to a Th17 phenotype, and can promote inflammatory disease in a model of pulmonary fibrosis. We also show that, contrary to findings in thymocyte populations, Egr3 expression does not inhibit Th17 activation in the periphery.
Materials and Methods

Mice
Egr3 TG mice on the B6.AKR background were obtained from G. Kersh, Emory University School of Medicine, Atlanta, Georgia [21] . The Egr3 TG mice were backcrossed onto C57 Bl/6 mice from Jackson Laboratories for at least five generations. This study was carried out in accordance with recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Johns Hopkins University Institutional Animal Care and Use Committee.
Cells, Abs, and reagents
Stimulatory anti-CD3 (2C11) and anti-CD28 (37.51) were isolated by affinity chromatography from hybridoma supernatants. Cytokines were purchased from Peprotech. PMA and ionomycin were purchased from Sigma. CD3-PE, CD4-APC, CD4-PE, CD8a-PE, CD8a-APC, CD8b-PE, CD8a-PerCP, cdTCR-FITC, (GL3), Vc4-FITC (UC310A6), CD25-PE, CD44-FITC, CD44-PerCP Cy5.5, CD62L-APC, CD90.1-PE, IFNc-APC, and IL-17-PerCP Cy5.5 antibodies were purchased from BD biosciences and used for flow cytometry. Vg1-FITC (2.11) and Vg7-FITC (F2.67) antibodies were generously donated by the Pereira lab. Lymphocytes were isolated from lung as described under the "Pulmonary Fibrosis Model." To isolate lymphocytes from small intestine and colon, tissues were harvested, sliced open longitudinally, washed several times in saline, and cut into small pieces. These pieces were then incubated with 0.1 mM EDTA, washed, then incubated in 1 mg/ml collagenase. Supernatant from these steps were collected, strained, and lymphocytes were separated from remaining epithelial cells using a 40% 60% Percoll gradient centrifugation step.CD4+ T cells were isolated from pooled spleen and lymph nodes of Egr3 TG mice using the CD4+ T cell negative isolation kit (Miltenyi Biotec). cd T cells were isolated by enriching splenocytes using a T cell negative isolation kit (Miltenyi Biotec) and positively selecting for cd T cells using a biotinylated cd TCR Ab (BD biosciences), streptavidin coated beads, and magnetic columns (Miltenyi Biotec). CD4+ CD44-CD62L+ naive T cells were collected by FACS sorting. The Heilig and Tonegawa nomenclature is used when referring to specific subsets of cd T cells.
T Cell Activation
For activation of T cells with APC costimulation, 10 7 whole splenocytes were cultured in a 6 well plate with soluble anti-CD3 at 2 mg/ml in 3 ml of media. After 48 h of stimulation, cells were collected, then added to 15 ml fresh media and cultured an additional 4 days. For CD4+ activation, 5610 6 purified CD4+ T cells or 5610 6 naive CD4+ T cells were stimulated in 1 ml in a 12 well dish with 2 mg/ml plate-bound anti-CD3 and 2 mg/ml soluble anti-CD28. After 48 hours, CD4+ T cells were expanded into 5 ml fresh media in a 6 well dish. All Th17 skewing was done by including IL-6 (10 ng/ml), TGFb (5 ng/ml), and IL-23 (10 ng/ml) in the initial stimulation media. No exogenous cytokines were added to Th0 stimulation media or cd coculture media. For cd skewing experiments, purified cd T cells were added to stimulation reaction at 1:1 ratio with CD4+ T cells, keeping the total T cell number constant. All cells were restimulated on day 6 for 4-6 hours with PMA (50 ng/ml) and ionomycin (500 ng/ml) prior to intracellular cytokine staining. For RT-PCR of splenocytes, cells were collected and lysed prior to stimulation (day 0), 24 hours post-stimulation (day 1), or after 48hour of stimulation and 4 days of rest followed by a 6 hour restimulation with 1 mg/ml platebound anti-CD3 and 2 mg/ml soluble anti-CD28 (day 6). For RT-PCR of purified T cells, freshly isolated CD4+ T cells and cd T cells were stimulated 16 hours with 1 mg/ml plate-bound anti-CD3 and 2 mg/ml soluble anti-CD28 prior to cells lysis for RT-PCR.
Quantitative Real Time PCR
Total RNA was isolated from cultured T cells using TRIzol reagent (Invitrogen). Reverse transcriptase was performed on 1 mg of total RNA with the SuperScript III reverse transcriptase kit (Invitrogen). Real-time PCR was performed using ready-made primer/probe sets for Egr3, Id3, IL-17A, IL-17F, IL-6, IL-21, IL23, IL-23R, RORct,18S endogenous control, and 2X PCR Master Mix (Applied Biosystems) on the ABI 7500 machine. Data were analyzed using SDS 1.5 software (Applied Biosystems). RNA abundance was calculated using the DCt method normalized to control 18S RNA and is plotted as 2 2DCt of isolated sample or time point divided by an unstimulated wildtype control (fold increase over baseline) unless otherwise indicated.
Pulmonary Fibrosis Model
Mice were anesthetized using ketamine and xylazine, and 0.025 U of bleomycin was instilled intratrachealy (i.t.). Mice were then monitored for weight loss and survival. To assess lymphocyte infiltration into the lungs, bleomycin was administered as above and mice were killed with a lethal injection of sodium pentathol (Ampro Pharmaceutical, Arcadia, CA). Bronchoalveolar lavage (BAL) was performed by cannulating the trachea then instilling and retrieving 1 ml of sterile normal saline. The entire lavage volume was centrifuged, and the cell pellet was resuspended in RPMI 1640 supplemented with FBS and antibiotics. Following cardiac perfusion, lungs were harvested, chopped in a petri dish with a sterile razor blade, then lightly crushed and washed with RPMI over a 10um cell strainer. Recovered lung-infiltrating lymphocytes were stimulated 5 hours for intracellular cytokine staining.
Results
Increased Th17 differentiation in Egr3 TG mice is cell extrinsic
While the ability of Egr3 overexpression to inhibit T cell activation has been demonstrated [4, 5] , this inhibition was measured through decreases in IL-2 production and proliferation, and the effects of Egr3 on T-helper differentiation have not been addressed. We hypothesized that Egr3 would inhibit Th17 differentiation in a similar fashion. To test this, we stimulated splenocytes from mice transgenically overexpressing Egr3 in T cells (Egr3 TG) or their wildtype counterparts (Egr3 WT) with or without the Th17 skewing cytokines IL-6, TGFb, and IL-23. After two days of stimulation, cells were expanded into fresh media, rested, and then restimulated with PMA and Ionomycin on day 6 for intracellular cytokine staining. Both Egr3 WT and Egr3 TG CD4+ T cells produce IL-17 when splenocytes were stimulated under skewing conditions (Th17), and surprisingly, a large fraction of Egr3 TG CD4+ T cells also produced IL-17 under non-skewing (Th0) conditions (Figure 1a ). To further explore this observation, we measured mRNA expression of various markers of the Th17 lineage by Egr3 WT and Egr3 TG splenocytes stimulated under non-skewing conditions. RORct, IL-6 and IL-21 expression was higher in Egr3 TG splenocytes, even prior to stimulation (day 0). After only 24 hours of stimulation (day 1), IL-17A and IL-17 F expression was also higher in Egr3 TG splenocytes. However, the greatest differences between Egr3 WT and Egr3 TG splenocytes was found after splenocyte reactivation (day 6), when IL-17A, IL-17F, RORct, IL-6, IL-21 and IL-23 mRNA levels were all significantly higher in Egr3 TG samples (Figure 1b) . Such findings are consistent with the generation of Th17 cells and suggest that in the absence of exogenous skewing cytokines, the splenic environment in Egr3 TG mice is conducive to Th17 skewing. Many types of cells can contribute to the cytokine milieu in the spleen; therefore, to assess the intrinsic ability of Egr3 TG CD4+ T cells to produce IL-17, naive CD4+ T cells were sorted from Egr3 WT or TG splenocytes and activated in the absence (Th0) or presence (Th17) of skewing cytokines. Not surprisingly, isolated CD4+ T cells make less IL-17 than those stimulated in the presence of other splenocytes. More importantly, we also found that naive CD4+ T cells from both Egr3 WT and Egr3 TG mice have a similar capacity to become Th17 cells ( Figure 1c ). Though we have previously shown that Egr3 TG CD4+ T cells are hyporesponsive in their ability to proliferate and produce IL-2 [4, 5] , our results here suggest that constitutive expression of Egr3 by T cells neither inhibits nor directly promotes Th17 generation in peripheral CD4+ lymphocytes. , and closer inspection reveals that while very few CD8+ ab T cells from either genotype express the CD8aa homodimer, there was a significantly higher proportion of CD8aa-expressing cd T cells in Egr3 TG mice compared to their wildtype counterparts ( Figure S1 ). The increase in cd T cell numbers in these mice is not limited to the lymphoid organs, as similar increases were also detected in the lung and intestinal mucosa of Egr3 TG mice (Figure 2c ). We subsequently analyzed the subsets of cd T cells by their Vc chain expression and found increases in all subsets that were assessed. The Vc1 and Vc4 subsets made up the largest fractions of cd T cells in the lymphoid organs of Egr3 TG mice, while the majority of cd T cells in the gut mucosa were either Vc1 or Vc7 subsets (Figure 2d) .
Egr3 promotes the development of cd T cells
The Egr transcription factors are known to play a role in thymocyte development and b-selection [21] [22] [23] [24] and increasing evidence suggests that this transcription factor also plays a role in determining cd T cells fate [25] [26] [27] . Developing cd T cells express higher levels of Egr1, Egr2 and Egr3 as well as the transcriptional regulator Id3 [26] , and ectopic expression of any of the Egrs can promote cd TCR rearrangement in vitro [25, 27] . It has also been shown that mice that transgenically overexpress Egr1 have increased numbers of thymic cd T cells. However, these studies did not address the functional properties of Egr1-induced cd T cells in the periphery or the ability of Egr3 to promote development of cd T cells that function in the periphery. Therefore, we assessed cd T cell development in Egr3 TG mice in order to determine whether our mouse model aligned with these findings.
To this end we harvested thymi from age-matched WT and Egr3 TG littermates and surface stained for the thymocyte subset markers CD4, CD8, CD44, and CD25. A decrease in thymic cellularity (not shown) and a robust increase in the percentage of CD4-CD8-(DN) thymocytes at the expense of the CD4+ CD8+ (DP) population in Egr3 TG mice (Figure 3a , left) is consistent with previous findings that Egr3 functions in survival and proliferation, during the DN to DP transition of developing ab thymocytes [21, 22, 24] . Further investigation revealed a slight increase in the proportion of the CD44-, CD25-(DN4) thymocyte subset ( Figure  3a , right) and an increase in both the percentage and absolute number of cd T cells in the thymus (Figure 3b and 3c) . It has been proposed that a strong TCR stimulus during thymic development, mediated by Id3, can promote cd development over ab selection [27] . To determine whether Egr3 might promote cd development through modulation of Id3, we sorted freshly isolated CD4-CD8-thymocytes into DN1 through DN4 subsets and compared the mRNA expression of Id3 in Egr3 WT and Egr3 TG samples by qRT-PCR. Id3 expression was increased in the DN2 through DN4 subsets from Egr3 TG mice (Figure 3d ). These results, along with the increased absolute number of peripheral cd T cells in Egr3 TG mice (Figure 2b, right) , support a role for Egr3 in promoting cd T cell selection and inhibiting ab T cell development in the thymus.
cd T cells from Egr3 TG mice are capable of skewing CD4+ T cells to Th17
Having demonstrated a role for Egr3 in promoting the generation of cd T cells and determining that these cd T cells are capable of populating the peripheral lymphoid organs, we wanted to determine whether cd T cells in the lymphoid compartment of Egr3 TG mice were functionally similar to those from Egr3 WT mice. When splenocytes from Egr3 WT and Egr3 TG littermate mice were activated, DN cd T cells from both genotypes produced significantly more IL-17 than CD8+ cd T cells, and the fraction of cd T cells producing IL-17 was equivalent between genotypes (Figure 4a ). Yet due to differences in their proportions within the spleen, there was a greater than 5-fold increase in absolute number of IL-17-producing cd T cells in the Egr3 TG sample (Figure 4a, bottom bar graph) . Early mRNA expression of IL-17A IL-17F, IL-6, and IL-23R was also found to be comparable between Egr3 WT and Egr3 TG cd T cells ( Figure  4b ). It is thought that cytokine expression by cd T cells may segregate in part according to different Vc subsets, with Vc4 T cells being a common producer of IL-17 [28] [29] [30] . To assess this in our model, we measured IL-17 production by the two cd T cell subsets with the largest increase in Egr3 TG mice. Not surprisingly, Vc4 T cells from both Egr3 WT and Egr3 TG mice produced more IL-17 than Vc1 T cells (Figure 4c ). Though IFNc production by these cd subsets appears lower than expected, we confirmed IFNc staining using stimulated ab T cells from the same Egr3 WT mice as a control ( Figure S2 ).
Our findings that both CD4+ T cells and cd T cells from Egr3 TG mice are capable of expressing IL-17 were surprising, given that Egr3 is thought to inhibit both RORct expression and function in thymocyte and cd T cell models [20, 31] . [20] . Taken together, our findings suggest that Egr3-induced cd T cells are similar to wildtype cd T cells in their ability to produce cytokine. The clearest difference between these genotypes is the increase in the absolute number of cd T cells (Figure 2b) , particularly the Vc4+ cd T cells, a subset shown to produce IL-17 and other cytokines involved in Th17 skewing and stabilization ( Figure 2d and Figure 4) .
It has been suggested that cd T cells have the ability to directly skew CD4+ T cells through the production of IL-17 [18] . Our findings suggest that the increased numbers of cd T cells found in Egr3 TG mice are able to contribute to this skewing milieu, in part through the expression of both IL-17 and IL-6. To directly test whether Egr3-induced cd T cells can skew CD4+ T cells, we isolated CD4+ T cells from Thy1.1-Egr3 WT mice and stimulated them alone, in the presence of Thy1.1+ Egr3TG cd T cells, or with Th17-skewing conditions. Note that the ''readout'' cells in this assay are wildtype CD4+ T cells, thus eliminating a cellintrinsic role for Egr3 in regulating Th17 production. CD4 and Thy1.1 were used to differentiate cell types within the co-culture, as it otherwise may have been difficult to separate cd T cells from CD4 T cells based on post-activation TCR expression (Figure 4d , top row). Plotting these two gates together (Figure 4d , top right) shows both that this gating strategy was successful and that large numbers of Egr3 TG cd T cells in this co-culture experiment produce IL-17. The addition of cd T cells to the stimulation consistently increased production of IL-17 by CD4+ T cells more than 2-fold (Figure 4d , bottom row and bar graph). This co-culture demonstrates the influence of cd T cells during CD4+ T cell activation and expansion, suggesting that prolonged exposure of CD4+ T cells to Egr3-induced cd T cells may promote the strong Th17 skewing seen in Egr3TG mice.
cd T cells from Egr3 TG mice promote inflammation in a model of pulmonary fibrosis
We next wanted to examine whether Egr3-induced cd T cells could promote an in vivo inflammatory response. To this end, we utilized Egr3WT and Egr3TG mice in a model of pulmonary fibrosis, a disease in which both cd T cells and IL-17 play a role [32, 33] . When mice were challenged with intratracheal (i.t.) bleomycin to induce inflammation and fibrosis, weight loss occurred faster and to a greater extent in Egr3TG mice compared to their Egr3 WT littermates (Figure 5a ). In addition, a larger fraction of Egr3TG mice died prior to day 25 ( Figure 5b ). In light of these observations, we wanted to examine the inflammatory responses in the lungs of the Egr3WT and Egr3TG mice. Mice were given i.t. bleomycin and sacrificed 5 days later to determine the levels of cell infiltration and cytokine production within the lungs. Both the BAL and lungs of bleomycin-treated Egr3 TG mice contained 2-3 fold more total cd T cells and a significantly higher number of IL-17-producing cd T cells than in wildtype mice (Figure 5c ). We also observed an increase in both total CD4+ T cell numbers and IL-17+ CD4+ T cell numbers in the BAL of Egr3 TG compared with Egr3 WT mice (Figure 5c ). This finding is particularly striking considering Egr3 TG mice have impaired ab T cell development and lower circulating numbers of CD4+ T cells (Figure 2 ). These data are consistent with the idea that Egr3-induced cd T cells are capable of inducing inflammation and disease either directly or through their influence on CD4+ T cells.
Discussion
Egr3 has been shown to be a negative regulator of CD4+ T cell responses and we initially undertook these experiments to examine the role of Egr3 in Th17 development. Surprisingly, we found that not only do Egr3 TG CD4+ T cells produce robust amounts of IL-17 but they skewed to become Th17 cells even under non skewing conditions. In pursuing this finding we revealed that this increase in Th17 differentiation in the Egr3 TG mice was not cell intrinsic. Rather, we demonstrate a role for Egr3 in the development of functional cd T cells that can influence the adaptive immune response and promote inflammatory disease. These Egr3-induced cd T cells reside in peripheral lymphoid organs as well as in circulation and in epithelial tissues, and are capable of producing cytokines at levels similar to wildtype cd T cells. We found that though CD4+ T cells from Egr3 TG mice are similar to those from Egr3 WT mice in their capacity to secrete IL-17, they are skewed toward a Th17 fate, in part by the increased ratio of cd T cells to CD4+ T cells in Egr3 TG mice. While we would have liked to compare the skewing ability of Egr3 WT and Egr3 TG cd T cells in our co-culture experiment (Figure 4d ), we were unable to isolate large enough numbers of Egr3 WT cd T cell to do this. It is therefore not our intent to suggest that Egr3-induced cd T cells are better at promoting a Th17 phenotype than wildtype cd T cells. It has been shown that wildtype cd T cells are capable of direct Th17 skewing [18] , and our data highlight that Egr3-induced cd T cells also possess this capability. Notably, our finding that Egr3-induced cd T cells possess the functionality of wildtype cd T cells, yet are present in larger numbers in the periphery, make them a potential model for further study of cd T cells and their ability to influence the adaptive immune response.
While we demonstrate the ability of the cd T cells to directly affect the skewing of CD4+ T cells, cd T cells may also influence APCs and other cells in the lymphoid compartment to aid in Th17 skewing and maintenance. Our finding that IL-23 mRNA is elevated in Egr3 TG splenocytes (Figure 1b) supports this idea. This would also explain the greater difference in IL-17 production between genotypes in the presence of antigen presenting cells (APCs) and other splenocytes which could contribute to the skewing milieu (Figure 1a compared to Figure 4d ). Our data support previous findings that innate-like cd T cells can profoundly influence T helper cell differentiation and adaptive Figure 1 . CD4+ T cells from Egr3 TG mice are biased toward Th17 differentiation. A-B) Splenocytes from 10-12 week old Egr3 WT and Egr3 TG mice were stimulated for 2 days with soluble anti-CD3 either with (Th17) or without (Th0) the addition of skewing cytokines. A) IL-17 production by Egr3 WT and Egr3 TG CD4+ T cells within the splenic population after restimulation. B) IL-17A, IL-17F, IL-21, RORct, IL-23, and IL-6 mRNA expression in unstimulated (day 0), overnight stimulated (day 1) or previously activated and restimulated (day 6) splenocytes from Egr3 WT and Egr3 TG mice. Cells stimulated for mRNA were not skewed and mRNA expression was determined by qRT-PCR done in triplicate and normalized to 18s expression. C) Naive CD4+ T cells from Egr3 WT and Egr3 TG mice were stimulated with anti-CD3 and anti-CD28 for 2 days with or without skewing cytokines as in A, then restimulated and assessed for IL-17 production. Data are representative of 3 independent experiments, each using 2 mice per genotype. *p#0.05, ** p#0.01, ***p#0.005 doi:10.1371/journal.pone.0087265.g001
Egr3-Induced cd T Cells Promote a Th17 Response PLOS ONE | www.plosone.org immune responses [18, 34, 35] . Our work also demonstrates an indirect role for Egr3 in promoting Th17 development, in which Egr3 promotes the development of cd T cells which can in turn drive Th17 differentiation.
cd T cells primarily produce either IFNc or IL-17 and these populations can be segregated by Vc chain usage or by surface marker expression. Vc4+ cells are considered one of the most common IL-17 producers in the periphery [28, 30] , and while IFNc-producing cd T cells are largely CD27+ NK1.1+, IL-17-producing cd T cells are most often CD27-and CCR6+ [36, 37] . Though there were increases in all measured subsets of cd T cells in Egr3 TG mice, one of the largest increases we found in the peripheral lymphoid organs was in this IL-17-associated Vc4+ subset. This is not surprising, as we believe Egr3 influences cd T cell development through promoting expression of Id3, and it has been reported that Id3-/-mice have a severe reduction of this particular subset of cd T cells in the spleen [27] . Preliminary work by our group suggests that while NK1.1 and CCR6 expression is similar between Egr3 WT and Egr3 TG cd T cells, IFNc producing cd T cells from Egr3 TG mice may be less likely to express CD27 than those from Egr3 WT mice (not shown). Future studies will more precisely define these findings.
It has also been suggested that IL-17 is produced by antigennaïve cd T cells, mediated by innate immune signals, while IFNc production is induced by TCR stimuli [38] [39] [40] . The idea that TCR activation inhibits IL-17 production is supported by work showing that developing thymocytes which engage Skint-1 upregulate Egr3, which in turn suppresses RORct expression and thus IL-17 production [31] . Though this would seem to conflict with our findings, most of the work by this group was done in thymocyte cultures, comparing Vc5 and Vc6 subsets of cd T cells which normally populate the skin and reproductive mucosa. The in vivo skint-1 knock-out models show little to no increase in IL-17 production by peripheral cd T cells [31] , while our IL-17 producing Egr3-induced cd T cells are both a different subset (Vc4) and from peripheral lymphoid organs which lack Skint-1 expression.
Though the idea that cd T cells can promote Th17 skewing is not new, we were initially surprised that CD4+ T cells and cd T cells which overexpressed Egr3 were both capable of producing IL-17. Egr3 has been established as a mediator of T cell anergy, and its overexpression is thought to inhibit T cell activation [4, 5] . One possible explanation is that the level of Egr3 necessary for complete RORct inhibition is not maintained in Egr3 TG mice. While Egr3 expression is higher in T cells from Egr3 TG mice both prior to-and at all time points after activation, the Egr3 transgene is expressed separately from the endogenous gene and the kinetics of Egr3 expression mimic that of the Egr3 WT mice, increasing to peak expression shortly after TCR engagement and returning to baseline levels just as quickly [21] (Figure S3 ). Egr3 has been shown to inhibit both RORct expression and function during thymocyte development, though this inhibition is similarly transient; RORct expression and function are restored once Egr3 expression drops [20] . With these latter points in mind, another possible explanation for increased IL-17 by Egr3-overexpressing CD4 T cells is that decreased IL-2 production by Egr3 TG T cells [5] balances any IL-17 inhibition by Egr3, as IL-2 plays a known role in inhibiting IL-17 expression [16, 41] . Overall, the finding that Egr3 TG CD4+ T cells are able to produce IL-17 has forced us to reconsider our definition of T cell anergy. Previous results led us to conclude that CD4+ T cells from Egr3 TG mice were anergic [4, 5] , but a cell that proliferates more slowly and does not produce IL-2 or IFNc is anergic only in the context of Th1 activation. We have shown here that transgenic overexpression of Egr3 does not inhibit Th17 differentiation in CD4+ T cells or IL-17 production by peripheral cd T cells. While this is a negative finding, it shows that the role of Egr3 in IL-17 production is more complex than we originally believed.
It is widely accepted that the cytokine milieu experienced by a CD4+ T cell during primary activation is responsible for its differentiation into one of the many T helper subsets [42] and there is growing evidence to suggest that cd T cells can contribute to this instructive environment [34, 35] . CD4+ T cells activated either in the presence of IL-6 and TGF-b, or IL-6, IL-1 and IL-23 both produce IL-17, but those skewed with TGF-b appear to be less inflammatory and fail to transfer susceptibility to experimental autoimmune encephalomyelitis (EAE) [15, 16] . Similarly, cd T cells cultured in vitro with IL-23 and IL-1 produce IL-17 and have been linked to amplification of a Th17 response and exacerbation of inflammatory disease [18] . We have demonstrated here for the first time that Egr3 TG mice have an abundance of IL-17-producing cd T cells, and that these Egr3-induced cd T cells are capable of skewing CD4+ T cells in vitro without the addition of recombinant cytokines. Our data support not only the idea that cd T cells shape the adaptive immune response, but also support a role for Egr3 in the development of this influential population of cells.
Though normally comprising 1-2% of circulating lymphocytes, cd T cells are found more abundantly in epithelial and mucosal tissues. These cells are capable of responding rapidly to stress, tissue damage, and infection and can modulate the adaptive immune response in either a tolerogenic or inflammatory manner [43] [44] [45] [46] [47] [48] . Recent work on the role of cd T cells and IL-17 in pulmonary fibrosis suggests that cd T cells amplify a Th17 response and promote inflammation, but differ on whether they amplify collagen deposition [32] , help to control fibrosis via production of CXCL10 or IL-22 [32, [49] [50] [51] or have no effect on fibrotic disease [33] . In this report we demonstrate an increase in morbidity and mortality in Egr3 TG mice using a model of lung fibrosis. Previous work by our lab have shown that Egr3 TG mice are less susceptible to autoimmune pneumonitis [5] , which at first seems to conflict with our current findings. However, while these experiments indicate less Th1 inflammation as measured by IFNc production, total numbers lung infiltrates were similar and IL-17 was not measured. Along these lines, it remains to be determined if in the autoimmune pneumonitis model, the presence of increased Egr3 cd T cells could actually be protective. Overall our findings suggest a role for Egr3 in promoting peripheral IL-17-producing cd T cells, reveal a selective role for Egr3 cd T cells in promoting tissue pathology, and offer a potential model for studying this population of cells. 
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